Craig is Senior Director of Global Business Development for Janssen Pharmaceuticals.One of the areas Craig supports is our Oncology franchise and has recently worked on a number of collaborations to advance therapies in multiple myeloma to hopefully achieve the goals of dramatically improving the lives of patients and ultimately to find a cure.
Additionally, Craig works with partners to improve diagnostic tools which can help physicians in patient management. As for riding, Craig has been a lifelong enthusiast.In high school he road across country with friends and in the more recent past competed in triathlons and an Ironman event. Looking forward to the ride and raising awareness (and funds!) to advance research to eventually cure this disease!!!
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.
About Janssen OncologyClick below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.
Learn More
